Document Detail


High-dose intravenous immunoglobulin in myasthenia gravis.
MedLine Citation:
PMID:  8314677     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of high-dose intravenous immunoglobulin (i.v.Ig) in 12 MG patients were studied. All patients had severe symptoms. In two cases anti-acetylcholine receptor antibodies (anti-AChR abs) were not detectable. I.v.Ig was administered to 9 patients already on long-term immunosuppressive therapy and to 3 patients at the beginning of azathioprine treatment. 10 patients (83%) improved; the duration of improvement was longer in immunosuppressed patients. Anti-AChR abs generally decreased after infusion but we did not find a constant correlation between reduction in ab titers and clinical improvement. Side effects included one case of severe hemolysis. In our experience i.v.Ig therapy is effective in MG. The chief indication for its use appears to be the treatment of deterioration of the disease in patients already on immunosuppressive therapy.
Authors:
A Evoli; M T Palmisani; E Bartoccioni; L Padua; P Tonali
Related Documents :
19417887 - Malignant transformation of oral lichen planus: a retrospective study of 23 cases.
3374767 - Tools to differentiate immunologic and non-immunologic myasthenia gravis in infancy.
1812447 - A prospective study of findings and management in 214 patients with oral lichen planus.
3376987 - Effects of repeated doses of intravenous immunoglobulin in myasthenia gravis.
20207827 - Pegvisomant-induced liver injury is related to the ugt1a1*28 polymorphism of gilbert's ...
6730887 - Hyperpotassemia during massive blood transfusions.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Italian journal of neurological sciences     Volume:  14     ISSN:  0392-0461     ISO Abbreviation:  Ital J Neurol Sci     Publication Date:  1993 Apr 
Date Detail:
Created Date:  1993-07-29     Completed Date:  1993-07-29     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8006502     Medline TA:  Ital J Neurol Sci     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  233-7     Citation Subset:  IM    
Affiliation:
Istituto di Neurologia, Università Cattolica, Roma.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Antibodies / analysis
Dose-Response Relationship, Drug
Female
Humans
Immunization, Passive*
Immunoglobulins / administration & dosage*
Injections, Intravenous
Male
Middle Aged
Myasthenia Gravis / immunology,  therapy*
Receptors, Cholinergic / immunology
Chemical
Reg. No./Substance:
0/Antibodies; 0/Immunoglobulins; 0/Receptors, Cholinergic

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acute hemispheric stroke: correlation between three-dimensional transcranial Doppler, MR-angiography...
Next Document:  The power of systematic genealogical study in familial Alzheimer disease.